CPT Code 90620: Meningococcal B Vaccine, 2-Dose (MenB-4C)

The 90620 CPT code covers a two-dose schedule of the meningococcal group B vaccine (MenB-4C). Each 0.5 ml intramuscular injection is administered at least one month apart, typically for young adults or patients at increased risk for invasive meningococcal disease.

The Centers for Disease Control and Prevention (CDC) recommends this outer membrane vesicle vaccine as part of immunization practices aimed at disease control and prevention.

Yes, CPT code 90620 is VFC-eligible for children and adolescents who meet CDC Vaccines for Children program criteria. Eligibility includes those at increased risk for meningococcal disease, such as individuals with immunosuppressed patient dosage needs or those exposed during outbreaks.

Healthcare providers must follow CDC guidelines and document services rendered properly for vaccine administration under this public health initiative.

Yes, the meningococcal group B vaccine (MenB-4C), billed under CPT code 90620, can be co-administered with other age-appropriate vaccines, such as hepatitis B vaccine, acellular pertussis vaccine, or rubella virus vaccine, during the same visit. Co-administration supports efficient active immunization and aligns with disease control strategies.

Each vaccine must be administered at separate injection sites, and any solicited adverse reactions (e.g., injection site pain) should be documented according to standard medical treatment protocols.